The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care.
The companies have come together to provide personalized testing that expands the possibilities of early cancer detection and precision diagnostics.
Big changes are coming soon to men’s healthcare: HALO Diagnostics and the Scionti Prostate Center will join forces to provide innovative focal therapy programs and comprehensive, multi-specialty care to the market.
Don’t let fiction trump facts when it comes to your prostate cancer or BPH treatment. Like you, many patients have questions about laser focal therapy (also known as “LFT,” and focal laser ablation, or “FLA”). Over the years, we’ve often found ourselves clearing up misconceptions or myths. With SO much
Patients in Northeast Florida are ready for a new kind of healthcare. By partnering with men’s and women’s health leader HALO Diagnostics, Precision Imaging Centers is ready to meet that need.
Before takeoff, flight attendants tell you to “put your oxygen mask on first” in case of an emergency. They tell you to do this so that you are able to breathe and survive while helping those around you. When it comes to prostate cancer awareness and prevention, knowledge is your
HALO Diagnostics is proud to now offer TULSA-PRO® as a treatment for prostate cancer and BPH. Dr. Ara Karamanian, head of HALO Dx’s Prostate Program, performs the procedure for the Prostate Laser Center, a HALO Dx company. For those with prostate cancer or benign prostatic hyperplasia (BPH), TULSA-PRO® and Laser
Biomarker, genetic, and genomic testing offer men new insights into their prostate health and help choose the best course of action.
Early detection saves lives. HALO is setting the new standard for prostate care.
